pbs tirzepatide Eli Lilly sues companies selling alternative versions of its weight loss drug FDA approves new version of

Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)

Orforglipron, as an oral tablet, has much simpler storage requirements

Can dark spots on the lips go away on their own

Concerning features include extensive urticaria, significant swelling beyond the injection site, intense pruritus, or rapid onset of symptoms

RGDS TanTrap Rated 5 out of 5 weelee560 (verified owner) Love this stuff

NHS/SACN 25(OH)D thresholds and the 10 g autumn/winter rule and why correcting vitamin D comes first, not a peptide